BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12933658)

  • 1. Lovastatin induces apoptosis of anaplastic thyroid cancer cells via inhibition of protein geranylgeranylation and de novo protein synthesis.
    Zhong WB; Wang CY; Chang TC; Lee WS
    Endocrinology; 2003 Sep; 144(9):3852-9. PubMed ID: 12933658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lovastatin suppresses invasiveness of anaplastic thyroid cancer cells by inhibiting Rho geranylgeranylation and RhoA/ROCK signaling.
    Zhong WB; Liang YC; Wang CY; Chang TC; Lee WS
    Endocr Relat Cancer; 2005 Sep; 12(3):615-29. PubMed ID: 16172195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of protein geranylgeranylation and RhoA/RhoA kinase pathway induces apoptosis in human endothelial cells.
    Li X; Liu L; Tupper JC; Bannerman DD; Winn RK; Sebti SM; Hamilton AD; Harlan JM
    J Biol Chem; 2002 May; 277(18):15309-16. PubMed ID: 11839765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lovastatin inhibits proliferation of anaplastic thyroid cancer cells through up-regulation of p27 by interfering with the Rho/ROCK-mediated pathway.
    Zhong WB; Hsu SP; Ho PY; Liang YC; Chang TC; Lee WS
    Biochem Pharmacol; 2011 Dec; 82(11):1663-72. PubMed ID: 21907187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lovastatin-induced PC-12 cell differentiation is associated with RhoA/RhoA kinase pathway inactivation.
    Fernández-Hernando C; Suárez Y; Lasunción MA
    Mol Cell Neurosci; 2005 Aug; 29(4):591-602. PubMed ID: 15951198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line.
    Ghosh PM; Ghosh-Choudhury N; Moyer ML; Mott GE; Thomas CA; Foster BA; Greenberg NM; Kreisberg JI
    Oncogene; 1999 Jul; 18(28):4120-30. PubMed ID: 10435593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin.
    Takeda N; Kondo M; Ito S; Ito Y; Shimokata K; Kume H
    Am J Respir Cell Mol Biol; 2006 Dec; 35(6):722-9. PubMed ID: 16858009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lovastatin induces apoptosis in malignant mesothelioma cells.
    Rubins JB; Greatens T; Kratzke RA; Tan AT; Polunovsky VA; Bitterman P
    Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1616-22. PubMed ID: 9603146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of epidermal growth factor-induced RhoA translocation and invasion of human pancreatic cancer cells by 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors.
    Kusama T; Mukai M; Iwasaki T; Tatsuta M; Matsumoto Y; Akedo H; Nakamura H
    Cancer Res; 2001 Jun; 61(12):4885-91. PubMed ID: 11406567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of lovastatin-induced apoptosis in intestinal epithelial cells.
    Agarwal B; Halmos B; Feoktistov AS; Protiva P; Ramey WG; Chen M; Pothoulakis C; Lamont JT; Holt PR
    Carcinogenesis; 2002 Mar; 23(3):521-8. PubMed ID: 11895868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP.
    Marcelli M; Cunningham GR; Haidacher SJ; Padayatty SJ; Sturgis L; Kagan C; Denner L
    Cancer Res; 1998 Jan; 58(1):76-83. PubMed ID: 9426061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells.
    Xia Z; Tan MM; Wong WW; Dimitroulakos J; Minden MD; Penn LZ
    Leukemia; 2001 Sep; 15(9):1398-407. PubMed ID: 11516100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lovastatin induces apoptosis of spontaneously immortalized rat brain neuroblasts: involvement of nonsterol isoprenoid biosynthesis inhibition.
    García-Román N; Alvarez AM; Toro MJ; Montes A; Lorenzo MJ
    Mol Cell Neurosci; 2001 Feb; 17(2):329-41. PubMed ID: 11178870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lovastatin induces apoptosis by inhibiting mitotic and post-mitotic events in cultured mesangial cells.
    Ghosh PM; Mott GE; Ghosh-Choudhury N; Radnik RA; Stapleton ML; Ghidoni JJ; Kreisberg JI
    Biochim Biophys Acta; 1997 Oct; 1359(1):13-24. PubMed ID: 9398081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamin B, caspase-3 activity, and apoptosis induction by a combination of HMG-CoA reductase inhibitor and COX-2 inhibitors: a novel approach in developing effective chemopreventive regimens.
    Swamy MV; Cooma I; Reddy BS; Rao CV
    Int J Oncol; 2002 Apr; 20(4):753-9. PubMed ID: 11894121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simvastatin potentiates tumor necrosis factor alpha-mediated apoptosis of human vascular endothelial cells via the inhibition of the geranylgeranylation of RhoA.
    Tang D; Park HJ; Georgescu SP; Sebti SM; Hamilton AD; Galper JB
    Life Sci; 2006 Sep; 79(15):1484-92. PubMed ID: 16740276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lovastatin suppresses erythropoietin receptor surface expression through dual inhibition of glycosylation and geranylgeranylation.
    Hamadmad SN; Hohl RJ
    Biochem Pharmacol; 2007 Aug; 74(4):590-600. PubMed ID: 17586475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein geranylgeranylation is critical for the regulation of survival and proliferation of lymphoma tumor cells.
    van de Donk NW; Schotte D; Kamphuis MM; van Marion AM; van Kessel B; Bloem AC; Lokhorst HM
    Clin Cancer Res; 2003 Nov; 9(15):5735-48. PubMed ID: 14654559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of geranylgeranylated proteins in human mesangial cell proliferation.
    Khwaja A; Sharpe CC; Noor M; Hendry BM
    Kidney Int; 2006 Oct; 70(7):1296-304. PubMed ID: 16929252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenyltransferase inhibitors induce apoptosis in proliferating thyroid cells through a p53-independent CrmA-sensitive, and caspase-3-like protease-dependent mechanism.
    Vitale M; Di Matola T; Rossi G; Laezza C; Fenzi G; Bifulco M
    Endocrinology; 1999 Feb; 140(2):698-704. PubMed ID: 9927296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.